Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was …
Over the last 12 months, insiders at Insulet Corporation have bought $20,600 and sold $14.51M worth of Insulet Corporation stock.
On average, over the past 5 years, insiders at Insulet Corporation have bought $1.02M and sold $24.56M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Chadwick Ana Maria (EVP, CFO & Treasurer) — $61,800.
The last purchase of 100 shares for transaction amount of $20,600 was made by Chadwick Ana Maria (EVP, CFO & Treasurer) on 2024‑08‑29.
2024-09-11 | Sale | director | 7,628 0.0108% | $225.26 | $1.72M | +2.30% | ||
2024-09-10 | Sale | director | 5,000 0.0071% | $225.84 | $1.13M | +2.68% | ||
2024-09-09 | Sale | SVP & Chief Technology Officer | 1,383 0.002% | $220.87 | $305,463 | +6.11% | ||
2024-09-09 | Sale | Group VP, CAO and Controller | 1,506 0.0022% | $221.41 | $333,443 | +6.11% | ||
2024-08-30 | Sale | SVP, Global Operations | 1,824 0.0026% | $202.27 | $368,940 | +14.38% | ||
2024-08-29 | EVP, CFO & Treasurer | 100 0.0001% | $206.00 | $20,600 | +13.01% | |||
2024-08-28 | Sale | SVP & Chief Technology Officer | 1,387 0.002% | $203.00 | $281,561 | +13.34% | ||
2024-06-14 | Sale | SVP & Chief Technology Officer | 1,500 0.0022% | $199.96 | $299,940 | +6.02% | ||
2024-06-10 | Sale | director | 7,000 0.0099% | $190.51 | $1.33M | +7.63% | ||
2024-06-10 | Sale | SVP & Chief Technology Officer | 2,131 0.003% | $190.43 | $405,806 | +7.63% | ||
2024-06-04 | Sale | director | 360 0.0005% | $182.58 | $65,729 | +12.83% | ||
2024-05-28 | Sale | director | 3,300 0.0048% | $180.90 | $596,970 | +14.68% | ||
2024-02-28 | Sale | director | 11,609 0.0166% | $162.92 | $1.89M | +14.02% | ||
2023-12-15 | Sale | director | 72 0.0001% | $207.08 | $14,910 | -7.21% | ||
2023-11-13 | Sale | director | 35,000 0.0502% | $164.63 | $5.76M | +16.31% | ||
2023-09-19 | SVP, Global Operations | 1 <0.0001% | $168.92 | $169 | +10.05% | |||
2023-08-28 | President and CEO | 5,550 0.008% | $181.41 | $1.01M | +0.03% | |||
2023-07-03 | Sale | EVP, CFO | 1,388 0.002% | $282.94 | $392,721 | -35.02% | ||
2023-06-20 | Sale | SVP, Chief HR Officer | 175 0.0003% | $290.00 | $50,750 | -35.79% | ||
2023-06-05 | Sale | director | 500 0.0007% | $283.38 | $141,690 | -34.74% |
Scannell Timothy J | director | 30586 0.0436% | $238.94 | 1 | 3 | +15.22% |
Hopfield Jessica | director | 26917 0.0384% | $238.94 | 2 | 1 | +45.84% |
Chadwick Ana Maria | EVP, CFO & Treasurer | 13314 0.019% | $238.94 | 1 | 0 | |
Singh Prem | SVP, Global Operations | 3656 0.0052% | $238.94 | 1 | 1 | |
SULLIVAN PATRICK J | CEO and Chairman of the Board | 261544 0.373% | $238.94 | 6 | 0 | +25.47% |
The Vanguard Group | $1.41B | 11.71 | 8.2M | +2.11% | +$29.05M | 0.03 | |
Capital Research Global Investors | $1.3B | 10.8 | 7.56M | -20.2% | -$328.15M | 0.29 | |
BlackRock | $1.03B | 8.6 | 6.03M | -1.26% | -$13.16M | 0.02 | |
Fidelity Investments | $926.06M | 7.71 | 5.4M | -8.02% | -$80.73M | 0.06 | |
State Street | $500.35M | 4.17 | 2.92M | +1.19% | +$5.87M | 0.02 |